Regen Lab SA (Regenlab) has failed to pay legal costs ordered by the UK High Court after revocation of its PRP patent for lack of novelty and inventive step. Regenlab is exposed to enforcement procedures which may limit its ability to provide products in the marketplace...
Estar Medical has been successful in revoking Regenlab's original PRP patent in the European Patent Office (EPO) opposition proceedings. This ruling follows a recent judgment by the UK High Court which also found the Regenlab PRP patent invalid for lack of novelty and inventive step...
The UK Court refused to grant Regenlab permission to appeal the finding that its European PRP patent is invalid...
The products shown in this webpage are not cleared by the U.S. FDA for sale in the USA.
© 2020 All rights reserved to Estar Medical UK Ltd.
